
Main Category: Breast Cancer
Also Included In: Cancer / Oncology;��Women's Health / Gynecology
Article Date: 14 Apr 2011 - 16:00 PDT



Current Article Ratings:
Patient / Public: | ![]() | 5 (2 votes) |
Healthcare Prof: | ![]() | 5 (2 votes) |
Scientists have developed a new test to identify patients with aggressive breast cancer who could benefit from a 10p-a-day diabetes drug.
They used a new method based on the food cancer cells eat to predict which patients had a poor prognosis. Excitingly, they suggest these patients could benefit from metformin, a cheap and safe diabetes drug which is showing great potential as a cancer treatment.
The findings come from the Breakthrough Breast Cancer Research Unit at the University of Manchester and Thomas Jefferson University in the USA and are published today in the journal Cell Cycle.
Professor Michael Lisanti, from the Breakthrough Breast Cancer Research Unit at the University of Manchester, said: "We've shown that the saying, 'you are what you eat' holds true for cancer. The food cancer cells consume is crucial to how well a patient does and what treatment they need.
"If cancer cells are consuming high-energy food, this makes a tumour more aggressive and harder to treat. However, patients could benefit from metformin, which cuts off this fuel supply. There is more work to do but this test could be an important new way of tailoring treatments to a patients needs, across a range of cancers."
Professor Lisanti's team first looked at cells in the laboratory and fed them high-energy foods, known as lactate and ketones. They found which genes were expressed based on this fuel supply, and developed a gene signature based on this.
They then looked at 219 breast cancer patients and studied which cancer cells fed on ketones and lactate. This food comes healthy cells nearby. They found those patients with cancer cells which consumed high levels of ketones and lactate were more likely to have their disease return, for it to spread to other organs and to die. The test combines the gene signature with the ketone and lactate food supply. This could show which patients are likely to have a poor prognosis - with those same patients potentially benefiting from metformin.
Professor Anthony Howell, Director of the Breakthrough Breast Cancer Research Unit in Manchester, said: "We have discovered important new insights into how cancers feed themselves. It is a step towards having each patient get the right treatment for them - what we call personalised medicine. We are looking at a new way to separate patients based on who should respond well to the treatments we have, and who might need something different.
"It is particularly encouraging that some of those treatments might already be in the doctor's drug cabinet, and cheap to prescribe. We have some way to go but we hope that drugs like metformin will be saving lives of breast cancer patients over the next few years."
Source
Breakthrough Breast Cancer
Please rate this article: (Hover over the stars then click to rate) | Patient / Public: | or | Health Professional: |

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
Privacy Policy | Terms and Conditions
MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd � 2004-2011 All rights reserved.
Source: http://www.medicalnewstoday.com/articles/222376.php
womens health fitness magazine women health insurance yeast infection women and health camden pregnant women health insurance
No comments:
Post a Comment